1. Home
  2. PLSE vs CSWC Comparison

PLSE vs CSWC Comparison

Compare PLSE & CSWC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • CSWC
  • Stock Information
  • Founded
  • PLSE 2014
  • CSWC 1961
  • Country
  • PLSE United States
  • CSWC United States
  • Employees
  • PLSE N/A
  • CSWC N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • CSWC Textiles
  • Sector
  • PLSE Health Care
  • CSWC Consumer Discretionary
  • Exchange
  • PLSE Nasdaq
  • CSWC Nasdaq
  • Market Cap
  • PLSE 1.2B
  • CSWC 1.1B
  • IPO Year
  • PLSE 2016
  • CSWC N/A
  • Fundamental
  • Price
  • PLSE $16.15
  • CSWC $19.97
  • Analyst Decision
  • PLSE Buy
  • CSWC Buy
  • Analyst Count
  • PLSE 1
  • CSWC 5
  • Target Price
  • PLSE $22.00
  • CSWC $23.50
  • AVG Volume (30 Days)
  • PLSE 133.2K
  • CSWC 639.2K
  • Earning Date
  • PLSE 11-05-2025
  • CSWC 11-03-2025
  • Dividend Yield
  • PLSE N/A
  • CSWC 12.49%
  • EPS Growth
  • PLSE N/A
  • CSWC N/A
  • EPS
  • PLSE N/A
  • CSWC 1.64
  • Revenue
  • PLSE N/A
  • CSWC $209,032,000.00
  • Revenue This Year
  • PLSE N/A
  • CSWC $14.60
  • Revenue Next Year
  • PLSE $700.00
  • CSWC $10.75
  • P/E Ratio
  • PLSE N/A
  • CSWC $12.46
  • Revenue Growth
  • PLSE N/A
  • CSWC 10.52
  • 52 Week Low
  • PLSE $13.77
  • CSWC $17.46
  • 52 Week High
  • PLSE $25.00
  • CSWC $23.86
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 37.34
  • CSWC 36.36
  • Support Level
  • PLSE $17.10
  • CSWC $20.05
  • Resistance Level
  • PLSE $18.35
  • CSWC $21.00
  • Average True Range (ATR)
  • PLSE 0.64
  • CSWC 0.37
  • MACD
  • PLSE -0.20
  • CSWC 0.04
  • Stochastic Oscillator
  • PLSE 3.66
  • CSWC 7.41

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About CSWC Capital Southwest Corporation

Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source company's revenue comprises interest income and dividend income from investments made as well as management fees.

Share on Social Networks: